Feyenally develops eyeTEST TM, a mobile application that performs remote eye examinations using objective testing methods via a smartphone camera. This solution provides objective refractive error verification, offering an accessible alternative to traditional specialist visits for consumers and various healthcare settings. The platform aims to increase access to eye care while streamlining diagnostics for medical providers.
Funding
Funding not disclosed

RFounders
Product
Problem
Globally, over a billion people lack access to adequate eye care due to logistical and affordability barriers, leading to preventable vision loss from uncorrected refractive errors. Simultaneously, eye care professionals are often burdened with routine tasks, diverting their attention from complex cases.
Solution
Feyenally offers a mobile-based remote eye examination platform, eyeTEST™, that enables users to assess their refractive error from home. The platform utilizes objective testing methodologies, capturing eye images and analyzing them with AI to determine refractive status. This digital ophthalmic solution aims to democratize access to eye care and enhance diagnostic efficiency by providing a convenient and cost-effective alternative to traditional in-person visits. The system is designed to be accessible to individuals in remote locations or those facing mobility challenges, thereby expanding the reach of essential eye health services.
Target Audience
The primary target audience includes individuals seeking convenient and affordable eye examinations, as well as healthcare providers, optical retailers, and public health organizations aiming to expand access to eye care services.
Features
- Mobile application for remote refractive error assessment using smartphone camera technology.
- Objective testing methods that rely on image analysis rather than subjective patient feedback.
- AI-powered algorithms for analyzing eye images to determine spherical error, cylindrical error, and axis.
- Guided testing process within the app to ensure user compliance and data quality.
- Potential for integration with other digital health platforms and electronic health records.
- Designed to be accessible on a wide range of smartphones, including older models, through advanced ML algorithms.
- Pursuing MDR and FDA certification for medical device compliance.